WHIPgroup has filed a Complaint before the United States International Trade Commission (ITC) on behalf of its client RegenLab USA. The Complaint alleges that RegenLab’s US Pat. No. 10.064,894, directed to a blood separator system for the preparation of platelet rich plasma, has been infringed by Estar Technologies, Ltd. and Eclipse MedCorp., LLC. RegenLab is seeking an exclusion order from the ITC to prevent importation of infringing products. The ITC instituted a formal investigation on March 7, 2019. The case is captioned In the Matter of Certain Blood Separation and Cell Preparation Devices, Inv. No. 337-TA-1147.
WHIPgroup has prevailed in another patent appeal before the Patent Trial and Appeal Board (PTAB). The invention relates to an adjustable piston with an inner plastic nut that helps withstand high frequency pulsing loads. The [Read More…]
Earlier this month WHIPgroup asked the Supreme Court to take up the important issue of whether a court can overlook factual allegations in a patentee’s infringement complaint at the pleading stage and find that the [Read More…]
WHIPgroup Successfully obtained patent allowance with an Appeal Brief. The invention is directed to an agitator ball mill, and has cams with specific ratios that improve mixing, cooling, and durability. The Patent Office rejected all [Read More…]